We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to ...

Thermo Fisher Scientific is flexing its biotech muscles in 2025, ranking third among the top healthcare stocks to watch. With ...

Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of $19.06 billion over 2022-2031, this sector presents promising opportunities for ...

The surge in autoimmune diseases, propelled by factors such as genetic predisposition, environmental triggers, and lifestyle changes, underpins the robust growth of the diagnostics market. With ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 2.13% to $427.50 Thursday, on what proved to be an all-around mixed ...

A new collaboration facility, opened by Thermo Fisher Scientific, will work to make cell therapy developers’ research more accessible and optimized.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $629.44, with a ...